CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open account
☰
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open account
✖

Vaccine Doubts Hit Sentiment

Article By: ,  Senior Market Analyst
November 27, 2020 4:06 AM
Thursday’s session was quiet owing to most traders sitting on their hands given the Thanksgiving holiday in the US.  Whilst the US markets are open for a half day, we’re not expecting much in the way of volume. Black Friday shopping is also offering another distraction.

European bourses are edging lower, as the vaccine optimism seen at the start of the week has completely fizzled now that questions are growing over the soundness of the AstraZeneca covid vaccine trial. The doubts could delay the cheap and easily transported vaccine from being approved quickly by regulators. 

The pharmaceutical giant is likely to run a new additional study to assess the efficacy of a lower dosage after a subgroup which accidentally received an initial half dose revealed the dose to be 90% effective. AstraZeneca share are trading 1% lower.
Chinese factory profits soar
Concerns over the vaccine are overshadowing news that Chinese industrial profits surged at the fastest pace since early 2017. Although the minrers are finding support from the knowledge that the recovery in the world’s largest consumer of metals was powering along nicely. This is a stark contrast to Europe and the US which are still battling to bring covid infections under control. 

UK’s gloomy outlook
The British government yesterday announced the UK Tier breakdown for when the national lockdown ends next week. With around 20 million Brits going from national lockdown to Tier 3, the toughest category the economic outlook for the UK remains particularly gloomy

Oil & gold struggle
Oil prices are declining on Friday in quiet trade amid concerns over oversupply and doubts over a vaccine to end the covid pandemic. Despite falling for a second straight session both Brent and WTI are on track to book gains in the region of 6% across the week.
Meanwhile, the risk off mood wasn’t helping gold, which continues to struggle for direction just north of $1800. 

FTSE Chart
After the FTSE’s strong run up at the start of the month on vaccine news, the rally has been consolidating in the horizontal channel of 6515 and 6325. The price is currently find support on the lower ban of the channel. A break through 6325 could open the door to a deeper selloff towards horizontal support at 6120 and then near 6000, the confluence of the 50,100 & 200 day moving average. 
Should support at 6325 hold then the FTSE could make another push towards 6500.

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024